Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN

Oncology Reports

Volumn 33, Issue 6, 2015, Pages 3108-3116

  Xu, Jingjie ^a,b   Zhang, Wei ^a   Lv, Qiongying ^a   Zhu, Dingjun ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Armed Police Inner Mongolia Unit Hospital   (China)

Author keywords

Cervical cancer cells; Migration; miR 21; Proliferation; PTEN

Indexed keywords

MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; MESSENGER RNA; MICRORNA; MIRN21 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTEN GENE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; UTERINE CERVIX CANCER; WART VIRUS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; GENETICS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 84928889340     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3931     Document Type: Article

References (47)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Movva S, Rodriguez L, Arias-Pulido H and Verschraegen C: Novel chemotherapy approaches for cervical cancer. Cancer 115: 3166-3180, 2009.
3. Sittidilokratna K, Cheewakriangkrai C, Khunamornpong S and Siriaunkgul S: Recurrence patterns after radical hysterectomy in stage IB1-IIA cervical. Asian Pac J Cancer Prev 11: 499-502, 2010.
4. zur Hausen H: Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1288: F55-F78, 1996.
5. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al: Retrospective international survey and HPV time trends study group: Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11: 1048-1056, 2010.
6. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC and Wacholder S: Human papillomavirus and cervical cancer. Lancet 370: 890-907, 2007.
7. Liao S, Deng D, Zhang W, Hu X, Wang W, Wang H, Lu Y, Wang S, Meng L and Ma D: Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo. Oncol Rep 29: 95-102, 2013.
8. Chen H, Suo K, Cheng Y, Zheng B and Xu L: Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase. Gynecol Endocrinol 29: 20-24, 2013.
9. Meng F, Zhao X and Zhang S: SHP-2 phosphatase promotes cervical cancer cell proliferation through inhibiting interferon-β production. J Obstet Gynaecol Res 39: 272-279, 2013.
10. Wu Y, Zhou X and Zheng PS: Involvement of CD147 isoform 4 in the proliferation of SiHa cells: A possible molecular mechanism of cervical cancer. Oncol Rep 26: 717-724, 2011.
11. Sun Y, Liu JH, Sui YX, Jin L, Yang Y, Lin SM and Shi H: Beclin1 overexpression inhibitis proliferation, invasion and migration of CaSki cervical cancer cells. Asian Pac J Cancer Prev 12: 1269-1273, 2011.
12. Song C, Zhu S, Wu C and Kang J: Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J Biol Chem 288: 28021-28033, 2013.
13. Siomi H and Siomi MC: Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38: 323-332, 2010.
14. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, et al: Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 14: 2535-2542, 2008.
15. Lui WO, Pourmand N, Patterson BK and Fire A: Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67: 6031-6043, 2007.
16. Pereira PM, Marques JP, Soares AR, Carreto L and Santos MA: MicroRNA expression variability in human cervical tissues. PLoS One 5: e11780, 2010.
17. Leung CO, Deng W, Ye TM, Ngan HY, Tsao SW, Cheung AN, Pang RT and Yeung WS: miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway. Carcinogenesis 35: 1931-1940, 2014.
18. Long MJ, Wu FX, Li P, Liu M, Li X and Tang H: MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. Cancer Lett 324: 186-196, 2012.
19. Xie H, Zhao Y, Caramuta S, Larsson C and Lui WO: miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One 7: e46990, 2012.
20. Yu J, Wang Y, Dong R, Huang X, Ding S and Qiu H: Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. J Cancer Res Clin Oncol 138: 671-674, 2012.
21. Tian RQ, Wang XH, Hou LJ, Jia WH, Yang Q, Li YX, Liu M, Li X and Tang H: MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis. J Biol Chem 286: 25556-25563, 2011.
22. Peng RQ, Wan HY, Li HF, Liu M, Li X and Tang H: MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine: polypeptide N-ace tylgalactosaminyltransferase 7. J Biol Chem 287: 14301-14309, 2012.
23. Wang Y, Li J, Tong L, Zhang J, Zhai A, Xu K, Wei L and Chu M: The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: A meta-analysis. Jpn J Clin Oncol 43: 813-820, 2013.
24. Liu ZL, Wang H, Liu J and Wang ZX: MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem 372: 35-45, 2013.
25. Xiong B, Cheng Y, Ma L and Zhang C: miR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Int J Oncol 42: 219-228, 2013.
26. Liu S, Fang Y, Shen H, Xu W and Li H: Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis. Acta Biochim Biophys Sin (Shanghai) 45: 756-762, 2013.
27. Teng Y, Manavalan TT, Hu C, Medjakovic S, Jungbauer A and Klinge CM: Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells. Toxicol Sci 131: 71-83, 2013.
28. Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, et al: Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 33: 1736-1744, 2012.
29. Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One 6: e28423, 2011.
30. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
31. Chu EC and Tarnawski AS: PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit 10: RA235-RA241, 2004.
32. Vázquez-Ulloa E, Lizano M, Avilés-Salas A, Alfaro-Moreno E and Contreras-Paredes A: Abnormal distribution of hDlg and PTEN in premalignant lesions and invasive cervical cancer. Gynecol Oncol 122: 663-668, 2011.
33. Hsieh SM, Maguire DJ, Lintell NA, McCabe M and Griffiths LR: PTEN and NDUFB8 aberrations in cervical cancer tissue. Adv Exp Med Biol 599: 31-36, 2007.
34. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007.
35. Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336, 2007.
36. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005.
37. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S and Cole CN: Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67: 11612-11620, 2007.
38. Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY: miR-21-mediated tumor growth. Oncogene 26: 2799-2803, 2007.
39. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, et al: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24: 4677-4684, 2006.
40. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
41. Sakai A, Thieblemont C, Wellmann A, Jaffe ES and Raffeld M: PTEN gene alterations in lymphoid neoplasms. Blood 92: 3410-3415, 1998.
42. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R and Ellenson LH: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57: 3935-3940, 1997.
43. Li DM and Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57: 2124-2129, 1997.
44. Li L, Ernsting BR, Wishart MJ, Lohse DL and Dixon JE: A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast. J Biol Chem 272: 29403-29406, 1997.
45. Maehama T and Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378, 1998.
46. Harima Y, Sawada S, Nagata K, Sougawa M, Ostapenko V and Ohnishi T: Mutation of the PTEN gene in advanced cervical cancer correlated with tumor progression and poor outcome after radiotherapy. Int J Oncol 18: 493-497, 2001.
47. Odar K, Boštjančič E, Gale N, Glavač D and Zidar N: Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck. Histopathology 61: 257-265, 2012.